Lodenafil

Profiles Drug Subst Excip Relat Methodol. 2022:47:113-147. doi: 10.1016/bs.podrm.2021.10.004. Epub 2021 Dec 7.

Abstract

Lodenafil is a class of drugs called an inhibitor of PDE5 which also include a wide range of other erectile medicines, such as sildenafil, tadalafil and vardenafil. It is part of a new generation of PDE5 inhibitors that includes udenafil and avanafil. Lodenafil is a prodrug manufactured in the form of lodenafil carbonate, the carbonate dimer that divides in the body into two active drug lodenafil molecules. The oral bioavailability of this formulation is higher than that of the parent drug. This article discusses, by a critical comprehensive review of the literature on lodenafil in terms of its description, names, formulae, elemental composition, appearance, and therapeutic uses. The article also discusses the methods for preparation of lodenafil, its physical-chemical properties, analytical methods for its determination, pharmacological-toxicological properties, and dosing information.

Keywords: Analytical methods; Clinical applications; Hydroxyhomosildenafil; Lodenafil; NMR; PDE5 inhibitors drugs; Physical description; Stability; Synthesis methods.

Publication types

  • Review

MeSH terms

  • Erectile Dysfunction* / drug therapy
  • Humans
  • Male
  • Phosphodiesterase 5 Inhibitors / pharmacology
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Sildenafil Citrate / therapeutic use
  • Tadalafil / therapeutic use
  • Vardenafil Dihydrochloride / therapeutic use

Substances

  • Phosphodiesterase 5 Inhibitors
  • Vardenafil Dihydrochloride
  • Tadalafil
  • Sildenafil Citrate